CETP inhibition, statins and diabetes

Barter, PJ; Cochran, BJ; Rye, KA

Barter, PJ (reprint author), Univ New South Wales, Sch Med Sci, Kensington, NSW 2033, Australia.

ATHEROSCLEROSIS, 2018; 278 (): 143

Abstract

Type 2 diabetes is a causal risk factor for the development of atherosclerotic cardiovascular disease (ASCVD). While treatment with a statin reduces t......

Full Text Link